Meier, Juris J.
Rosenstock, Julio
Article History
First Online: 21 September 2016
Competing interests
: J.R. has served on scientific advisory boards and received honorarium or consulting fees from AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo, Eli Lilly, Intarcia, Janssen, Merck, Novo Nordisk and Sanofi. He has received grants and/or research support from Asahi, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly, GlaxoSmithKline, Hanmi, Intarcia, Janssen, Lexicon, MannKind, Merck, Novo Nordisk, Pfizer, Sanofi and Takeda. J.J.M. has received consulting and speaker honoraria from AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novo Nordisk and Sanofi. He has received research support from Boehringer Ingelheim, Eli Lilly, Merck, Novartis, Novo Nordisk and Sanofi.